AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Deutsche Bank AG

Director's Dealing May 13, 2021

99_rns_2021-05-13_b01bea26-a16f-42b8-800b-d05951134492.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5602Y

Deutsche Bank AG

13 May 2021

Ap24

FORM 38.5(a)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

1.       KEY INFORMATION

Name of exempt principal trader Deutsche Bank AG London
Company dealt in UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 1) Ordinary Shares
Date of dealing 12/05/2021

2.        DEALINGS (Note 2)

(a)      Purchases and sales

Total number of relevant securities acquired Highest price paid (Note 3) Lowest price paid

(Note 3)
Total number of securities disposed Highest price received (Note 3) Lowest price received

(Note 3)
1,977 10.3000 GBP 10.2900 GBP

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 4)
Number of relevant securities

(Note 5)
Price per unit

(Note 3)

EUR
Equity Swap Reducing a Short Position 1,977 10.2979 GBP

Ap25

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 5) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 3)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 3)

3.      OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.          

Date of disclosure 13/05/2021
Contact name Gurpreet Kaur Kang
Telephone number 0121 407 8493
Name of offeree/offeror with which connected Nenelite Limited
Nature of connection (Note 6) Financial Adviser and Corporate Broker

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEBGGDUGUBDGBX

Talk to a Data Expert

Have a question? We'll get back to you promptly.